Thanks, Mike. Yesterday, we filed our earnings press release in Form 10-Q, which provide extensive detail of our financials. So I will focus on some key highlights. Starting with the income statement during the second quarter, the ODR segment accounted for 47.1% of total consolidated revenue, up from 42.9%, last year. ODR revenues during the quarter was up 18.1% from a year ago, while GCR revenue was essentially flat resulting in consolidated top line growth of 7.5%. We continue to see solid execution in the quarter. Consolidated gross margin during the second quarter was 22.8%, primarily due to increasing contribution from our higher margin ODR segment and strong overall margin performance in both segments. For the quarter GCR gross margin was 17.1% while ODR margin was 29.3%. SG&A expense of $20.4 million during the quarter was down modestly from $21.1 million in the first quarter and up from $18.7 million in the year ago period. The increase in SG&A expense from the year ago period was primarily related to increases in payroll related expenses of $1.3 million and a $500,000 increase in stock-based compensation expense. These increases were partially offset by a $400,000 decrease in rent related expenses. As we noted on our call last quarter, we expect full year 2023 SG&A expense as a percentage of total revenue to have a similar annual run rate as 2022. Now turning to cash flow, we continue to have a strong balance sheet. At quarter end, our cash and cash equivalents balance was $45.9 million and we had $10 million outstanding on our revolver. We exited the quarter in a net cash position of $23.6 million compared to a net cash position of $4.2 million at the end of December. As we have previously noted our ODR focus and tightened GCR project selection process, are expected to provide a better operating cash flow profile. Our strong execution during the second quarter contributed to operating cash flow of $16.9 million compared with $15.6 million a year ago. Changes in working capital accounts had a positive impact of $7.6 million on the operating cash flow and accounts receivable provided cash of $12.5 million as a result of strong collections in the quarter. Offsetting some of the increase we used $6.8 million of cash in accounts payable. The remaining $9.3 million of operating cash flow was a non-working capital component. As we've noted previously our free cash flow can be calculated by taking this figure and then subtracting CapEx which totaled $576,000 in the quarter. That leaves free cash flow of $8.8 million or around 74% of our adjusted EBITDA. Cash conversion for the quarter came in better then the 70% annual target level. Our primary use of the cash we generate continues to be the reduction of debt and the funding of our acquisition program. With our current cash balances and our expected free cash flow, we believe we have ample capital to pursue our acquisition program without needing any equity financing. Subsequent to quarter end, we utilized just over $5 million of cash on hand to finance the acquisition of ACME. Lastly, during the second quarter, all 600,000 of the $15 exercised price sponsored warrants were exercised on a cashless basis, resulting in the issuance of approximately 168,000 shares of our common stock. In addition of the roughly 630,000, $12.50 exercised price merger warrants, approximately 163,000 were exercised on a cashless basis during the quarter, resulting in issuance of approximately 46,000 shares of our common stock. In total, nearly 213,000 shares of common stock were issued during the second quarter as a result of warrants exercised. Of the remaining merger warrants outstanding at June 30, approximately 443,000 of those warrants were exercised prior to their expiration on July 20, resulting in the additional issuance of approximately 229,000 shares of our common stock in July. As of August 7, we had approximately 11 million shares outstanding inclusive of all of the warrant exercised. This share count can be located on the cover of our Form 10-Q. I'll now hand it back to Mike.